StreetInsider.com News Articles

Form 6-K Moolec Science SA For: Jun 02

Tue, 02 Jun 2026 08:45:00 -0400

si-local-file:///var/storage/secattach/20260602/26588309.html

Form 6-K Moolec Science SA For: Jun 02

Tue, 02 Jun 2026 08:45:00 -0400

si-local-file:///var/storage/secattach/20260602/26588309.html

Form 6-K Moolec Science SA For: May 14

Thu, 14 May 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260514/26495400.html

Form 6-K Moolec Science SA For: May 14

Thu, 14 May 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260514/26495400.html

Moolec Science completes 2026 GLASO safflower planting in US

Thu, 14 May 2026 09:03:20 -0400

Moolec Science Limited, a subsidiary of Moolec Science SA (NASDAQ: MLEC), completed its 2026 commercial planting campaign for GLASO safflower in the United States. The company announced the completion of planting activities that began May 4, 2026, in the American Falls region of Idaho.

The safflower program focuses on producing high-GLA (Gamma-Linolenic Acid) specialty oils for industrial and advanced ingredient applications. All production fields were planted following soil preparation, irrigation optimization, and seed conditioning protocols designed to maximize germination performance and crop establishment.

Moolec reported that its GLASO platform achieved GLA concentrations of approximately 45% in previous operations. The company has identified

Moolec Science Successfully Completes 2026 GLASO Commercial Planting Campaign in the United States

Thu, 14 May 2026 09:00:00 -0400

WARWICK, GB / ACCESS Newswire / May 14, 2026 / Moolec Science Limited, a wholly owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced the successful completion of the 2026 commercial planting campaign for its GLASO¹ safflower program focused on the production of high-GLA ("Gamma-Linolenic Acid") specialty oils for industrial and advanced ingredient applications.

"Today represents a defining moment for Moolec. Regaining compliance with Nasdaq while simultaneously advancing the commercial execution of our

Moolec Science Successfully Completes 2026 GLASO Commercial Planting Campaign in the United States

Thu, 14 May 2026 09:00:00 -0400

WARWICK, GB / ACCESS Newswire / May 14, 2026 / Moolec Science Limited, a wholly owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced the successful completion of the 2026 commercial planting campaign for its GLASO¹ safflower program focused on the production of high-GLA ("Gamma-Linolenic Acid") specialty oils for industrial and advanced ingredient applications.
"Today represents a defining moment for Moolec. Regaining compliance with Nasdaq while simultaneously advancing the commercial execution of our

Form 6-K Moolec Science SA For: May 13

Thu, 14 May 2026 06:07:00 -0400
si-local-file:///var/storage/secattach/20260514/26489151.html

Form 6-K Moolec Science SA For: May 13

Thu, 14 May 2026 06:07:00 -0400
si-local-file:///var/storage/secattach/20260514/26489151.html

Form 6-K Moolec Science SA For: May 13

Wed, 13 May 2026 17:19:00 -0400
si-local-file:///var/storage/secattach/20260513/26487578.html

Form 6-K Moolec Science SA For: May 13

Wed, 13 May 2026 17:19:00 -0400
si-local-file:///var/storage/secattach/20260513/26487578.html

Moolec Science completes first phase of GLASO safflower industrialization

Wed, 29 Apr 2026 09:05:26 -0400

Moolec Science SA (NASDAQ: MLEC) announced the completion of the first phase of industrialization for its GLASO safflower platform following a 2025 campaign that exceeded internal forecasts, according to a company statement.
The biotechnology company confirmed it achieved approximately 45% gamma-linolenic acid (GLA) concentration at commercial scale and validated industrial-scale handling and processing capabilities. The 2025 campaign produced high-purity GLA output that surpassed expected yields, enabling large-scale harvesting and integration with downstream industrial processes.
Moolec plans to begin sowing for its 2026 GLASO campaign in early May, continuing its scaling strategy across existing U.S. agricultural infrastructure. Initial market activity has focused on

Moolec Science Confirms Completion of First Phase of GLASO Industrialization Following Record 2025 Campaign; Advances 2026 Sowing and Expands Into Energy Applications

Wed, 29 Apr 2026 09:03:00 -0400

WARWICK, UK / ACCESS Newswire / April 29, 2026 / Moolec Science Limited, a wholly-owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced the successful completion of the first phase of industrialization of its GLASO¹ safflower platform, following a 2025 campaign that materially exceeded all internal forecasts.
Building on previously reported results confirming approximately 45% GLA ("Gamma-linolenic acid") concentration at commercial scale, the Company has now validated not only agronomic and processing performance,

Moolec Science Confirms Completion of First Phase of GLASO Industrialization Following Record 2025 Campaign; Advances 2026 Sowing and Expands Into Energy Applications

Wed, 29 Apr 2026 09:03:00 -0400

WARWICK, UK / ACCESS Newswire / April 29, 2026 / Moolec Science Limited, a wholly-owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced the successful completion of the first phase of industrialization of its GLASO¹ safflower platform, following a 2025 campaign that materially exceeded all internal forecasts.
Building on previously reported results confirming approximately 45% GLA ("Gamma-linolenic acid") concentration at commercial scale, the Company has now validated not only agronomic and processing performance,

Form 6-K Moolec Science SA For: Apr 15

Wed, 15 Apr 2026 16:48:00 -0400
si-local-file:///var/storage/secattach/20260415/26319092.html

Form 6-K Moolec Science SA For: Apr 15

Wed, 15 Apr 2026 16:48:00 -0400
si-local-file:///var/storage/secattach/20260415/26319092.html

Form 3 Moolec Science SA For: Apr 15 Filed by: Core Daniel Joaquin

Wed, 15 Apr 2026 16:01:00 -0400
si-local-file:///var/storage/secattach/20260415/26318279.html

Form 3 Moolec Science SA For: Apr 15 Filed by: Core Daniel Joaquin

Wed, 15 Apr 2026 16:01:00 -0400
si-local-file:///var/storage/secattach/20260415/26318279.html

Form SCHEDULE 13D/A Moolec Science SA Filed by: Agriculture Investment Group Corp.

Wed, 08 Apr 2026 16:05:00 -0400
si-local-file:///var/storage/secattach/20260408/26289271.html

Form SCHEDULE 13D/A Moolec Science SA Filed by: Agriculture Investment Group Corp.

Wed, 08 Apr 2026 16:05:00 -0400
si-local-file:///var/storage/secattach/20260408/26289271.html

Moolec Science expresses bovine myoglobin in pea seeds for first time

Tue, 07 Apr 2026 08:16:54 -0400

Moolec Science SA (NASDAQ: MLEC) announced it has successfully expressed bovine myoglobin in pea seeds through a 28-month research project with a U.S. academic institution. The company stated this represents the first reported case of producing the heme-containing protein in pea seeds.
The research demonstrated stable expression of the protein across generations, confirming reproducibility and genetic stability. Moolec deployed proprietary constructs in the legume crop, validating what the company describes as platform flexibility for its molecular farming technology.
The project established pea seeds as a production system for recombinant proteins. Pea is a protein-rich crop with established supply chains and industrial adoption

Form SCHEDULE 13D Moolec Science SA Filed by: Agriculture Investment Group Corp.

Tue, 07 Apr 2026 08:08:00 -0400
si-local-file:///var/storage/secattach/20260407/26280840.html

Form SCHEDULE 13D Moolec Science SA Filed by: Agriculture Investment Group Corp.

Tue, 07 Apr 2026 08:08:00 -0400
si-local-file:///var/storage/secattach/20260407/26280840.html

Moolec Science Announces Breakthrough in Molecular Farming With Successful Expression of Bovine Myoglobin in Pea Seeds

Tue, 07 Apr 2026 08:00:00 -0400

WARWICK, GB / ACCESS Newswire / April 7, 2026 / Moolec Science Limited, a wholly owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced a significant scientific breakthrough in the production of animal proteins in plants.
Through a sponsored research project with one of the most prestigious academic institutions in the United States of America, Moolec has successfully demonstrated the stable expression of bovine myoglobin, a heme-containing protein, within the seeds of the

Moolec Science Announces Breakthrough in Molecular Farming With Successful Expression of Bovine Myoglobin in Pea Seeds

Tue, 07 Apr 2026 08:00:00 -0400

WARWICK, GB / ACCESS Newswire / April 7, 2026 / Moolec Science Limited, a wholly owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced a significant scientific breakthrough in the production of animal proteins in plants.
Through a sponsored research project with one of the most prestigious academic institutions in the United States of America, Moolec has successfully demonstrated the stable expression of bovine myoglobin, a heme-containing protein, within the seeds of the